Pharmacotherapeutics
Pharmacotherapeutics
for Advanced
for Advanced
Practice
for Advanced
Practice
Nurse Prescribers
Practice
Nurse Prescribers
Nurse
Chapter
Prescribers
Chapter
38 HeartChapter
38
Failure
Heart38
Study
Failure
Heart
Guide
Study
Failure
Key
Guide
Study
Drugs
Key
Guide
and
Drugs
Management
Keyand
Drugs
Management
and
(1).pdf
Management
(1).pdf (1).pdf
Pharmacotherapeu
tics for Advanced
Practice Nurse
Prescribers
Chapter 38 Heart
Failure Study
Guide Key Drugs
and Management
Pharmacotherapeutics
Pharmacotherapeutics
Pharmacotherapeutics
for Advanced
for Advanced
Practice
for Advanced
Practice
Nurse Prescribers
Practice
Nurse Prescribers
Nurse
Chapter
Prescribers
Chapter
38 HeartChapter
38
Failure
Heart38
Study
Failure
Heart
Guide
Study
Failure
Key
Guide
Study
Drugs
Key
Guide
and
Drugs
Management
Keyand
Drugs
Management
and
(1).pdf
Management
(1).pdf (1).pdf
,Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf
Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf
Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf
Terms in this set (24)
Angiotensin-converting-enzyme (ACE) inhibitors are a ANS: 3
central part of the treatment of heart failure (HF)
because they have more than one action to address the
pathological changes in this disorder. Which of the
following pathological changes that take place in HF is
NOT addressed by ACE inhibitors?
1. Changes in the structure of the left ventricle so that it
dilates, hypertrophies, and uses energy less efficiently
2. Reduced formation of cross-bridges so that
contractile force decreases
3. Activation of the sympathetic nervous system that
increases heart rate and preload
4. Decreased renal blood flow that decreases oxygen
supply to the kidneys
Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf
Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf
Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf
Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf
Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf
One of the three types of HF involves systolic ANS: 1
dysfunction. Potential causes of this most common form
of HF include:
1. Myocardial ischemia and injury secondary to
myocardial infarction (MI)
2. Inadequate relaxation and loss of muscle fiber
secondary to valvular dysfunction
3. Increased demands of the heart beyond its ability to
adapt secondary to anemia
4. Slower filling rate and elevated systolic pressures
secondary to uncontrolled hypertension
Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf
Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf
Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter 38. Heart Failure.pdf